Legacy Capital Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,192
| Closed | -$1.61M | – | 161 |
|
|
2019
Q3 | $1.61M | Sell |
16,192
-12,460
| -43% | -$1.18M | 0.7% | 48 |
|
|
2019
Q2 | $2.65M | Sell |
28,652
-790
| -3% | -$75K | 1.18% | 28 |
|
|
2019
Q1 | $2.78M | Buy |
29,442
+1,580
| +6% | +$138K | 1.3% | 28 |
|
|
2018
Q4 | $1.79M | Sell |
27,862
-84
| -0.3% | -$6.2K | 0.95% | 41 |
|
|
2018
Q3 | $2.5M | Buy |
27,946
+500
| +2% | +$44.2K | 1.15% | 34 |
|
|
2018
Q2 | $2.18M | Sell |
27,446
-300
| -1% | -$24.9K | 1.07% | 36 |
|
|
2018
Q1 | $2.48M | Sell |
27,746
-3,615
| -12% | -$347K | 1.24% | 32 |
|
|
2017
Q4 | $3.27M | Sell |
31,361
-245
| -0.8% | -$27.6K | 1.62% | 23 |
|
|
2017
Q3 | $4.61M | Buy |
31,606
+2,086
| +7% | +$284K | 2.42% | 8 |
|
|
2017
Q2 | $3.83M | Sell |
29,520
-289
| -1% | -$35.4K | 2.07% | 14 |
|
|
2017
Q1 | $3.71M | Buy |
29,809
+1,885
| +7% | +$226K | 2.08% | 13 |
|
|
2016
Q4 | $3.23M | Buy |
27,924
+259
| +0.9% | +$28.8K | 1.96% | 15 |
|
|
2016
Q3 | $2.89M | Hold |
27,665
| – | – | 1.82% | 18 |
|
|
2016
Q2 | $2.73M | Buy |
27,665
+310
| +1% | +$32.1K | 1.7% | 19 |
|
|
2016
Q1 | $2.74M | Sell |
27,355
-1,315
| -5% | -$135K | 1.77% | 17 |
|
|
2015
Q4 | $3.43M | Sell |
28,670
-1,500
| -5% | -$174K | 2.21% | 12 |
|
|
2015
Q3 | $3.26M | Buy |
30,170
+1,550
| +5% | +$192K | 2.21% | 12 |
|
|
2015
Q2 | $3.31M | Sell |
28,620
-1,680
| -6% | -$192K | 2.16% | 12 |
|
|
2015
Q1 | $3.49M | Sell |
30,300
-1,605
| -5% | -$192K | 2.23% | 10 |
|
|
2014
Q4 | $3.57M | Sell |
31,905
-521
| -2% | -$54.9K | 2.28% | 10 |
|
|
2014
Q3 | $3.07M | Sell |
32,426
-2,826
| -8% | -$255K | 2.04% | 13 |
|
|
2014
Q2 | $3.03M | Buy |
35,252
+10,134
| +40% | +$771K | 1.96% | 15 |
|
|
2014
Q1 | $1.75M | Sell |
25,118
-1,350
| -5% | -$107K | 1.24% | 27 |
|
|
2013
Q4 | $2.24M | Sell |
26,468
-2,900
| -10% | -$229K | 1.59% | 21 |
|
|
2013
Q3 | $2.26M | Sell |
29,368
-2,290
| -7% | -$160K | 1.69% | 17 |
|
|
2013
Q2 | $1.85M | Buy |
+31,658
| New | +$1.91M | 1.41% | 21 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Legacy Capital Partners's CELG Position: Q4 2019 in Review
Legacy Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,192 shares — an estimated $1.61M sold.
Legacy Capital Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.61M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Legacy Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Legacy Capital Partners sold 16,192 Celgene Corp shares in Q4 2019, an estimated $1.61M.
- Legacy Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Legacy Capital Partners's Celgene Corp position peaked at $4.61M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Legacy Capital Partners's 13F filing for Q4 2019, filed 14 Jan 2020.